The global Chronic Lymphocytic Leukemia (CLL) therapeutics market is witnessing substantial growth due to the increasing prevalence of blood cancers, advancements in targeted therapies, and rising investments in oncology research. Pharmaceutical companies are focusing on innovative treatment approaches, including immunotherapy and precision medicine, to improve patient outcomes and reduce...